Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Organon
Pharma
Organon pays up to $1.2B to acquire Dermavant and its drug Vtama
With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a potential blockbuster in tow.
Fraiser Kansteiner
Sep 18, 2024 10:09am
Organon to assume Emgality marketing duties in 11 new countries
Aug 20, 2024 10:50am
Med techs take Gold, Grand Prix in Pharma Lions awards
Jun 18, 2024 4:00am
The top 10 drugs losing US exclusivity in 2024
Mar 11, 2024 3:00am
NY attorney general wants FDA to tweak Singulair's safety label
Feb 27, 2024 9:25am
After Lilly accord, Organon's CEO is hungry to ink more deals
Feb 16, 2024 8:50am
